Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaquet, D.
Right arrow Articles by Lévy-Marchal, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaquet, D.
Right arrow Articles by Lévy-Marchal, C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:3473-3478, 2002
© 2002 by the American Diabetes Association, Inc.

Combined Effects of Genetic and Environmental Factors on Insulin Resistance Associated With Reduced Fetal Growth

Delphine Jaquet1, David A. Trégouët2, Thierry Godefroy2, Viviane Nicaud2, Didi Chevenne3, Laurence Tiret2, Paul Czernichow1, and Claire Lévy-Marchal1

1 INSERM Unit 457; Hôpital R. Debré, Paris, France
2 INSERM Unit 525, Faculté de Médecine de la Pitié, Paris, France
3 Department of Biochemistry, Hôpital R. Debré, Paris, France

It has been suggested that the insulin resistance (IR) associated with reduced fetal growth results from interactions between genetic factors and an unfavorable fetal environment. In addition, the adipose tissue seems to play a key role in this association. We investigated whether polymorphisms in tumor necrosis factor (TNF)-{alpha}(G-308A), ß3 adrenoreceptor (ADRB3)(G+250C), and peroxisome proliferator-activated receptor (PPAR)-{gamma}2(Pro12Ala), key molecules of the adipose tissue, might affect the IR associated with reduced fetal growth. They were genotyped in 171 subjects who were born small for gestational age (SGA) and in 233 subjects who were born appropriate for gestational age (AGA) and underwent an oral glucose tolerance test (OGTT). The SGA group showed higher serum insulin concentrations than the AGA group at fasting (P = 0.03) and after stimulation (P = 0.0007), whereas no difference in serum glucose concentrations was observed. The frequencies of the alleles of these three polymorphisms were similar in both groups. In neither group did the polymorphisms affect glucose tolerance. In the SGA group, fasting insulin-to-glucose ratios were significantly higher in the TNF/-308A (P = 0.03), the PPAR/Ala12 (P = 0.01), and the ADRB3/+250G (P = 0.02) carriers than in the noncarriers. Results were comparable for fasting insulin concentration and insulin excursion under OGTT. No such amplification was observed in the AGA group. The effects of the PPAR/ProAla12 (P = 0.005) and the ADRB3/G+250G (P = 0.009) gene polymorphisms on IR indexes were significantly potentiated by BMI in the SGA group. In conclusion, our data exemplify the interaction between intrauterine environmental and genetic factors in the development of the IR associated with reduced fetal growth. They also point to the key role of adipose tissue in this association.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. Meirhaeghe, C. A.G. Boreham, L. J. Murray, F. Richard, G. D. Smith, I. S. Young, and P. Amouyel
A Possible Role for the PPARG Pro12Ala Polymorphism in Preterm Birth
Diabetes, February 1, 2007; 56(2): 494 - 498.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Karlberg, H. Jalanko, J. Kallijarvi, A.-E. Lehesjoki, and M. Lipsanen-Nyman
Insulin Resistance Syndrome in Subjects With Mutated RING Finger Protein TRIM37
Diabetes, December 1, 2005; 54(12): 3577 - 3581.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. Knouff and J. Auwerx
Peroxisome Proliferator-Activated Receptor-{gamma} Calls for Activation in Moderation: Lessons from Genetics and Pharmacology
Endocr. Rev., December 1, 2004; 25(6): 899 - 918.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
X. Wang, Y. Cui, X. Tong, H. Ye, and S. Li
Effects of the Trp64Arg Polymorphism in the {beta}3-Adrenergic Receptor Gene on Insulin Sensitivity in Small for Gestational Age Neonates
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4981 - 4985.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. A. Veening, M. M. van Weissenbruch, R. J. Heine, and H. A. Delemarre-van de Waal
{beta}-Cell Capacity and Insulin Sensitivity in Prepubertal Children Born Small for Gestational Age: Influence of Body Size During Childhood
Diabetes, July 1, 2003; 52(7): 1756 - 1760.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.